IP(400mg)Imatinib

Jun 20, 2023

Imatinib IP (400mg)
IMATIFLOW 400
Imatinib IP refers to the active pharmaceutical ingredient (API) called Imatinib. Imatinib is a tyrosine kinase inhibitor that is used in the treatment of certain types of cancer. It is primarily used to treat chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and some other rare blood disorders.
The "IP" in Imatinib IP stands for "Indian Pharmacopoeia." The Indian Pharmacopoeia (IP) is a book of standards for drugs and pharmaceuticals published by the Indian government. The inclusion of "IP" in the name indicates that the Imatinib meets the quality standards set by the Indian Pharmacopoeia.
400mg, refers to the amount of Imatinib contained in each tablet or capsule. The specific dosage and dosing schedule of Imatinib can vary depending on the condition being treated, the patient's individual factors, and the prescribing doctor's instructions.
STERIS PHARMA Generic medicines are typically much cheaper than brand-name drugs. Generic medicines have the same active ingredients, strength, dosage form, and route of administration as their brand-name counterparts.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/imatiflow-400-133660

SHARE WITH